DVL3 and lung carcinoma: For example, differential expression of several WNT components including WNT1, WNT2, WNT7A, DVL3, β-CATENIN and APC, have been reported in normal lung tissues and lung cancers, particularly in NSCLC (non-small cell lung cancer) [33-36].